Pregabalin dispensing patterns in Amman-Jordan: An observational study from community pharmacies

OBJECTIVES: Pregabalin is currently approved for the treatment of epilepsy, generalized anxiety disorder, neuropathic pain and fibromyalgia. Rising attention to the abuse liability of pregabalin causing addictive behaviors is partially based on case reports and published literature of pregabalin use...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Husseini, Amneh, Abu-Farha, Rana, Wazaify, Mayyada, Van Hout, Marie Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856951/
https://www.ncbi.nlm.nih.gov/pubmed/29556121
http://dx.doi.org/10.1016/j.jsps.2018.01.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856951/
https://www.ncbi.nlm.nih.gov/pubmed/29556121
http://dx.doi.org/10.1016/j.jsps.2018.01.012

Ejemplares similares